Author: almaware

Original Article

Quality of life improvement with allergen immunotherapy treatment in patients with rhinoconjunctivitis in real life conditions. Results of an observational prospective study (ÍCARA)

/ by almaware

Read more »

Original Article

Favorable clinical efficacy of mepolizumab on the upper and lower airways in severe eosinophilic asthma: a 48-week pilot study

/ by almaware

Read more »

Original Article

Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective

/ by almaware

   

Read more »

Letter to the Editor

Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management

/ by almaware

Read more »

Original Article

Isoforms of Group 1 Allergens from a Tropical/Subtropical Para Grass (Urochloa mutica) Display Different Levels of IgE Reactivity and Cross-reactivity

/ by almaware

Read more »

Brief report

Frequency of allergic sensitization to Can f 5 in North East Italy. An analysis of 1403 ISACs 112 (Component Resolved Diagnosis) collected retrospectively

/ by almaware

Read more »

Original Article

The incidence of immunofluorescence patterns and specific autoantibodies observed in autoimmune patients in a tertiary care centre

/ by almaware

Read more »

Original Article

Circulating microRNAs as potential non-invasive biomarkers in pediatric patients with celiac disease

/ by almaware

Read more »

Review

Allergy immunotherapies for allergic rhinitis: systematic review and assessment of evolving quality

/ by almaware

Read more »

Letter to the Editor

When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation

/ by almaware

Read more »

To top